4-102723925-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005908.4(MANBA):​c.315G>A​(p.Thr105Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0303 in 1,610,210 control chromosomes in the GnomAD database, including 3,646 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.093 ( 1778 hom., cov: 32)
Exomes 𝑓: 0.024 ( 1868 hom. )

Consequence

MANBA
NM_005908.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.401

Publications

5 publications found
Variant links:
Genes affected
MANBA (HGNC:6831): (mannosidase beta) This gene encodes a member of the glycosyl hydrolase 2 family. The encoded protein localizes to the lysosome where it is the final exoglycosidase in the pathway for N-linked glycoprotein oligosaccharide catabolism. Mutations in this gene are associated with beta-mannosidosis, a lysosomal storage disease that has a wide spectrum of neurological involvement. [provided by RefSeq, Jul 2008]
MANBA Gene-Disease associations (from GenCC):
  • beta-mannosidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 4-102723925-C-T is Benign according to our data. Variant chr4-102723925-C-T is described in ClinVar as Benign. ClinVar VariationId is 347099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.401 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.285 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MANBANM_005908.4 linkc.315G>A p.Thr105Thr synonymous_variant Exon 3 of 17 ENST00000647097.2 NP_005899.3 O00462
MANBAXM_047415692.1 linkc.240G>A p.Thr80Thr synonymous_variant Exon 4 of 18 XP_047271648.1
MANBAXM_047415693.1 linkc.240G>A p.Thr80Thr synonymous_variant Exon 4 of 18 XP_047271649.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MANBAENST00000647097.2 linkc.315G>A p.Thr105Thr synonymous_variant Exon 3 of 17 NM_005908.4 ENSP00000495247.1 O00462

Frequencies

GnomAD3 genomes
AF:
0.0932
AC:
14140
AN:
151764
Hom.:
1763
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.289
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0436
Gnomad ASJ
AF:
0.00808
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.0156
Gnomad FIN
AF:
0.00703
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0175
Gnomad OTH
AF:
0.0727
GnomAD2 exomes
AF:
0.0348
AC:
8712
AN:
250228
AF XY:
0.0296
show subpopulations
Gnomad AFR exome
AF:
0.300
Gnomad AMR exome
AF:
0.0316
Gnomad ASJ exome
AF:
0.00497
Gnomad EAS exome
AF:
0.000545
Gnomad FIN exome
AF:
0.00791
Gnomad NFE exome
AF:
0.0173
Gnomad OTH exome
AF:
0.0264
GnomAD4 exome
AF:
0.0238
AC:
34643
AN:
1458328
Hom.:
1868
Cov.:
29
AF XY:
0.0226
AC XY:
16407
AN XY:
725682
show subpopulations
African (AFR)
AF:
0.296
AC:
9831
AN:
33186
American (AMR)
AF:
0.0330
AC:
1472
AN:
44650
Ashkenazi Jewish (ASJ)
AF:
0.00609
AC:
159
AN:
26110
East Asian (EAS)
AF:
0.000328
AC:
13
AN:
39574
South Asian (SAS)
AF:
0.0164
AC:
1408
AN:
85894
European-Finnish (FIN)
AF:
0.00738
AC:
394
AN:
53390
Middle Eastern (MID)
AF:
0.0452
AC:
260
AN:
5758
European-Non Finnish (NFE)
AF:
0.0171
AC:
18991
AN:
1109482
Other (OTH)
AF:
0.0351
AC:
2115
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.448
Heterozygous variant carriers
0
1371
2743
4114
5486
6857
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0935
AC:
14197
AN:
151882
Hom.:
1778
Cov.:
32
AF XY:
0.0909
AC XY:
6745
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.290
AC:
11988
AN:
41390
American (AMR)
AF:
0.0435
AC:
664
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00808
AC:
28
AN:
3464
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5178
South Asian (SAS)
AF:
0.0158
AC:
76
AN:
4806
European-Finnish (FIN)
AF:
0.00703
AC:
74
AN:
10526
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0175
AC:
1186
AN:
67942
Other (OTH)
AF:
0.0715
AC:
151
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
545
1091
1636
2182
2727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0372
Hom.:
1082
Bravo
AF:
0.105
Asia WGS
AF:
0.0330
AC:
116
AN:
3474
EpiCase
AF:
0.0182
EpiControl
AF:
0.0183

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 23, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 25, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Beta-D-mannosidosis Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
8.9
DANN
Benign
0.72
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6857760; hg19: chr4-103645082; API